Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., . . . Schneider, S. M. (2010). Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and ageing, 39(4), 412-423. doi:
https://doi.org/10.1093/ageing/afq034
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., . . . Sayer, A. A. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing, 48(1), 16-31. doi:
https://doi.org/10.1093/ageing/afy169
Espeland, M. A., Gill, T. M., Guralnik, J., Miller, M. E., Fielding, R., Newman, A. B., & Pahor, M. (2007). Designing clinical trials of interventions for mobility disability: results from the lifestyle interventions and independence for elders pilot (LIFE-P) trial. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 62(11), 1237-1243. doi:
https://doi.org/10.1093/gerona/62.11.1237
Gellhaus, B., Böker, K. O., Schilling, A. F., & Saul, D. (2023). Therapeutic Consequences of Targeting the IGF-1/PI3K/AKT/FOXO3 Axis in Sarcopenia: A Narrative Review. Cells, 12(24), 2787. doi:
https://doi.org/10.3390/cells12242787
Gibney, J., Healy, M.-L., & Sönksen, P. H. (2007). The growth hormone/insulin-like growth factor-I axis in exercise and sport. Endocrine reviews, 28(6), 603-624. doi: h
ttps://doi.org/10.1210/er.2006-0052
Grassi, D., Lippi, C., Necozione, S., Desideri, G., & Ferri, C. (2005). Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. The American Journal of Clinical Nutrition, 81(3), 611- 614. doi:
https://doi.org/10.1093/ajcn/81.3.611
Gulick, C., Peddie, M., Jowett, T., Hackney, A., & Rehrer, N. (2020). Exercise, dietary protein, and combined effect on IGF-1. International journal of science and research methodology, 16(3), 61. Jiang, J.-j., Chen, S.-m., Chen, J., Wu, L., Ye, J.-t., & Zhang, Q. (2022). Serum IGF-1 levels are associated with sarcopenia in elderly men but not in elderly women. Aging Clinical and Experimental Research, 34(10), 2465-2471. URL:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7869853/
Hata, S., Mori, H., Yasuda, T., Irie, Y., Yamamoto, T., Umayahara, Y., . . . Shimomura, I. (2021). A low serum IGF-1 is correlated with sarcopenia in subjects with type 1 diabetes mellitus: Findings from a post-hoc analysis of the iDIAMOND study. Diabetes Research and Clinical Practice, 179, 108998. doi:
https://doi.org/10.1016/j.diabres.2021.108998
Jing, Y., Zuo, Y., Yu, Y., Sun, L., Yu, Z., Ma, S., . . . Li, J. (2023). Single-nucleus profiling unveils a geroprotective role of the FOXO3 in primate skeletal muscle aging. Protein & Cell, 14(7), 497-512. doi:
https://doi.org/10.1093/procel/pwac061
Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J., & Jørgensen, T. (2002). Low serum insulinlike growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation, 106(8), 939-944. doi:
https://doi.org/10.1161/01.CIR.0000027563.44593.CC
Kraemer, W. J., Adams, K., Cafarelli, E., Dudley, G. A., Dooly, C., Feigenbaum, M. S., . . . Hoffman, J. R. (2002). American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Medicine and science in sports and exercise, 34(2), 364-380. doi:
https://doi.org/10.1097/00005768-200202000-00027
Lang, T., Streeper, T., Cawthon, P., Baldwin, K., Taaffe, D. R., & Harris, T. (2010). Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporosis international, 21, 543-559. doi:
https://doi.org/10.1007/s00198-009-1059-y
Li, T.-C., Wu, C.-W., Li, C.-I., Wu, F.-Y., Liao, L.-N., Liu, C.-S., . . . Lin, C.-C. (2020). Interactions among IGF-1, AKT2, FOXO1, and FOXO3 variations and between genes and physical activities on physical performance in community-dwelling elders. PLoS ONE, 15(9), e0239530. doi:
https://doi.org/10.1371/journal.pone.0239530
Liguori, I., Russo, G., Aran, L., Bulli, G., Curcio, F., Della-Morte, D., . . . Bonaduce, D. (2018). Sarcopenia: assessment of disease burden and strategies to improve outcomes. Clinical interventions in aging, 913-927. URL:
https://www.tandfonline.com/doi/full/10.2147/CIA.S149232#d1e223
Liu, J., Chen, M., Xia, X., Wang, Z., Wang, Y., & Xi, L. (2024). Causal associations between the insulin-like growth factor family and sarcopenia: a bidirectional Mendelian randomization study. Frontiers in Endocrinology, 15, 1422472. doi:
https://doi.org/10.3389/fendo.2024.1422472
Moradi, Y., Zehsaz, F., & Nourazar, M. A. (2020). Concurrent exercise training and Murf-l and Atrogin-1 gene expression in the vastus lateralis muscle of male Wistar rats. Apunts Sports Medicine, 55(205), 21-27. doi:
https://doi.org/10.1016/j.apunsm.2020.02.001
Mousavi, M., & Ghazalian, F. (2020). Effect of eight weeks water resistance training with dark chocolate supplementation on the balance of the elderly. Journal of Shahid Sadoughi University of Medical Sciences. doi:
https://doi.org/10.18502/ssu.v28i8.4455
Nemecz, G. (2005). The health benefits of dark chocolate: nutrition. Journal of Modern Pharmacy, 12(6), 43-46. URL:
https://journals.co.za/doi/pdf/10.10520/AJA16836707_1648
Oh, H.-J., Jin, H., Lee, J.-Y., & Lee, B.-Y. (2023). Silk peptide ameliorates sarcopenia through the regulation of akt/mTOR/FOXO3a signaling pathways and the inhibition of low-grade chronic inflammation in aged mice. Cells, 12(18), 2257. doi:
https://doi.org/10.3390/cells12182257
Rolland, Y., Czerwinski, S., Van Kan, G. A., Morley, J., Cesari, M., Onder, G., . . . Boirie, Y. (2008). Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. The Journal of nutrition, health and aging, 12(7), 433-450. doi:
https://doi.org/10.1007/BF02982704
Sadri, S., Sharifi, G., & Dehkordi, K. J. (2020). Effects of high intensity interval training (up & downward running) with BCAA/nano chitosan on Foxo3 and SMAD soleus muscles of aging rat. Life sciences, 252, 117641. doi:
https://doi.org/10.1016/j.lfs.2020.117641
Santos, B. F., Grenho, I., Martel, P. J., Ferreira, B. I., & Link, W. (2023). FOXO family isoforms. Cell death & disease, 14(10), 702. doi:
https://doi.org/10.1038/s41419-023-06177-1
Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B., & Sandri, M. (2013). Mechanisms regulating skeletal muscle growth and atrophy. The FEBS journal, 280(17), 4294-4314. doi:
https://doi.org/10.1111/febs.12253
Wilkinson, D. J., Piasecki, M., & Atherton, P. (2018). The age-related loss of skeletal muscle mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans. Ageing research reviews, 47, 123-132. doi:
https://doi.org/10.1016/j.arr.2018.07.005
Ziaaldini, M. M., Marzetti, E., Picca, A., & Murlasits, Z. (2017). Biochemical pathways of sarcopenia and their modulation by physical exercise: a narrative review. Frontiers in medicine, 4, 167. doi:
https://doi.org/10.3389/fmed.2017.00167
Widajanti, N., Soelistijo, S., Hadi, U., Thaha, M., Aditiawardana, Widodo, . . . Srinowati, H. (2022). Association between Sarcopenia and Insulin‐Like Growth Factor‐1, Myostatin, and Insulin Resistance in Elderly Patients Undergoing Hemodialysis. Journal of aging research, 2022(1), 1327332. doi:
https://doi.org/10.1155/2022/1327332
Yoshida, T., & Delafontaine, P. (2020). Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells, 9(9), 1970. doi:
https://doi.org/10.3390/cells9091970
Zhao, Y., & Liu, Y.-S. (2021). Longevity factor FOXO3: a key regulator in aging-related vascular diseases. Frontiers in Cardiovascular Medicine, 8, 778674. doi:
https://doi.org/10.3389/fcvm.2021.778674